Variant report
Variant | esv275272 |
---|---|
Chromosome Location | chr11:93332181-93336949 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs16919071 | chr11:93335048-93335049 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs570785434 | chr11:93335096-93335097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs537893846 | chr11:93335118-93335119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs550445789 | chr11:93335189-93335190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568798914 | chr11:93335192-93335193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs369735155 | chr11:93335201-93335202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs536041557 | chr11:93335225-93335226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562536210 | chr11:93335230-93335231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs10831070 | chr11:93335266-93335267 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs566297273 | chr11:93335279-93335280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs187245592 | chr11:93335302-93335303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11820018 | chr11:93335339-93335340 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs576760714 | chr11:93335442-93335443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs190477670 | chr11:93335492-93335493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182501008 | chr11:93335493-93335494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs574358058 | chr11:93335552-93335553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs7928672 | chr11:93335556-93335557 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs186690236 | chr11:93335608-93335609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs527494306 | chr11:93335617-93335618 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs141373150 | chr11:93335635-93335636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs564469998 | chr11:93335636-93335637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs190657208 | chr11:93335649-93335650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs549940390 | chr11:93335663-93335664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568481241 | chr11:93335711-93335712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs372846977 | chr11:93335766-93335767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs36188500 | chr11:93335784-93335785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs527695287 | chr11:93335803-93335804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs370704939 | chr11:93335817-93335818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs548111034 | chr11:93335869-93335870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566234562 | chr11:93335872-93335873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs4341497 | chr11:93335882-93335883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs370145615 | chr11:93335901-93335902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs567753968 | chr11:93335933-93335934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs537964452 | chr11:93335942-93335943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555713564 | chr11:93336077-93336078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs111395296 | chr11:93336097-93336098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs4396249 | chr11:93336125-93336126 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs112125873 | chr11:93336141-93336142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs556750153 | chr11:93336182-93336183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs553692147 | chr11:93336183-93336184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs572202972 | chr11:93336253-93336254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs185477303 | chr11:93336273-93336274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs572066810 | chr11:93336278-93336279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs377737355 | chr11:93336305-93336306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs189553086 | chr11:93336307-93336308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs138870603 | chr11:93336325-93336326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs182249096 | chr11:93336365-93336366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs541051427 | chr11:93336397-93336398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs371134545 | chr11:93336423-93336424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs114717319 | chr11:93336461-93336462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Mental retardation | 21062444 | CNVD |
Cancer | 21499728 | CNVD |
Breast cancer | 19181860 | CNVD |
Breast cancer | 17603634 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Breast cancer | 21509527 | CNVD |
Prostate cancer | 18632612 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:93335000-93335200 | Enhancers | Primary monocytes fromperipheralblood | blood |
2 | chr11:93335000-93335200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
3 | chr11:93335200-93336600 | Weak transcription | Primary monocytes fromperipheralblood | blood |
4 | chr11:93335200-93336600 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
5 | chr11:93336600-93337400 | Enhancers | H1 Cell Line | embryonic stem cell |
6 | chr11:93336600-93337400 | Enhancers | Spleen | Spleen |
7 | chr11:93336600-93337400 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
8 | chr11:93336600-93337800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr11:93336600-93337800 | Enhancers | Fetal Intestine Small | intestine |
10 | chr11:93336600-93338000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr11:93336600-93339600 | Enhancers | Primary monocytes fromperipheralblood | blood |
12 | chr11:93336800-93337000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr11:93336800-93337000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
14 | chr11:93336800-93337200 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
15 | chr11:93336800-93337200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
16 | chr11:93336800-93337400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
17 | chr11:93336800-93337600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
18 | chr11:93336800-93337800 | Enhancers | Duodenum Mucosa | Duodenum |
19 | chr11:93336800-93337800 | Enhancers | Fetal Intestine Large | intestine |